Status:
COMPLETED
Effect of Virtual Reality-based Training on Balance and Walking in Youth With Autism Spectrum Disorder
Lead Sponsor:
Indiana University
Conditions:
Autism Spectrum Disorder
Eligibility:
All Genders
7-22 years
Phase:
NA
Brief Summary
The goal of this clinical trial is to assess the effect of short-term (3 days/week for 2 weeks) Virtual Reality (VR) active video gaming intervention on static and dynamic balance, versus traditional ...
Detailed Description
Postural control deficits, also referred to as balance deficits, are a noted example of impaired motor-skills and are increasingly considered as one of the primary markers for autism spectrum disorder...
Eligibility Criteria
Inclusion
- age 7-22 years,
- existing ASD DSM-5 level 1 or 2 diagnosis confirmed by medical record/ educational services categorized under ASD/ therapeutic services categorized under ASD/ any other official document indicating the diagnosis of ASD,
- able to follow instructions and
- able to stand unsupported for at least 20 minutes.
Exclusion
- epilepsy or other medical conditions which can be exacerbated by looking at a screen,
- Uncorrected vision loss or any other eye condition prohibiting looking at the screen for a prolong time,
- co-occurring musculoskeletal conditions such as joint or muscle pain or stiffness that limits mobility, implanted plates, pins, or screws that limit mobility, fractures or recent surgeries or any other physical condition that could interfere with the ability to play an active video game
- co-occurring neurological conditions such as numbness or muscle weakness, temporary loss of vision, speech or strength, loss of consciousness (black out), Dizziness or lightheadedness, Impaired memory or confusion, any other cooccurring diagnosis that could be negatively impacted by playing an active video game
- any other health conditions that are contraindicated to or may interfere with physical activity such as impaired hearing (uncorrected), medically documented balance disorder, Any heart condition prohibiting exercise, chronic pain or any pain at the time of testing, need assistance to stand for 20 minutes or more,
- aggression or other severe behaviors that may limit the ability to safely participate in the intervention.
Key Trial Info
Start Date :
May 15 2023
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 19 2024
Estimated Enrollment :
13 Patients enrolled
Trial Details
Trial ID
NCT06023563
Start Date
May 15 2023
End Date
April 19 2024
Last Update
August 12 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Indiana University Bloomington
Bloomington, Indiana, United States, 47405